A Novel PCNA Inhibitor with Promising Therapeutic Potential for Cancer Treatment

Jan 20, 2024

∙ Paid

Topline:

The groundbreaking study unveils AOH1996, a new proliferating cell nuclear antigen (PCNA) inhibitor, as a potent anti-cancer agent with minimal side effects, offering a new avenue for cancer therapy.

Study Details:

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.